Pharmacological analysis of synaptically mediated increase in cyclic adenosine monophosphate in rabbit superior cervical ganglion.
D000241:Adenosine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D001626:Bethanechol Compounds / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002217:Carbachol / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D004558:Electric Stimulation; D004987:Ethers / Q000494:pharmacology; D005727:Ganglia, Spinal / Q000378:metabolism*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D013948:Moxisylyte / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010726:Phosphodiesterase Inhibitors; D011817:Rabbits; D013015:Sotalol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology; D013569:Synapses / Q000502:physiology*; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors
D001593:Benzyl Compounds; D001626:Bethanechol Compounds; D004987:Ethers; D006584:Hexamethonium Compounds; D007093:Imidazoles; D010276:Parasympatholytics; D010726:Phosphodiesterase Inhibitors; D013565:Sympatholytics; D010643:Phenoxybenzamine; D001285:Atropine; D002217:Carbachol; D013015:Sotalol; D013806:Theophylline; D000242:Cyclic AMP; D000241:Adenosine; D013948:Moxisylyte; D002118:Calcium; D010646:Phentolamine